Flow Cytometry References
Researchers around the world and across many scientific
disciplines rely on the MoFlo® High-Performance Cell Sorter. A
partial list of journal articles highlighting some of their cutting-edge
K., X. He, J. Chen, H. Iwasaki, C. Niu, B. Steenhard, J. Zhang, J. Haug, and L.
Li. 2003. Transcriptional accessibility for genes of multiple tissues and
hematopoietic lineages is hierarchically controlled during early hematopoiesis.
A., P. Seale, A. Girgis-Gabardo, and M. A. Rudnicki. 2002. Myogenic
specification of side population cells in skeletal muscle. J. Cell Biol.
N., M. Farzan, D. S. Friend, H. Ochi, K. S. Price, J. Sodroski, and J. A.
Boyce. 2001. Human mast cell progenitors can be infected by macrophagetropic
human immunodeficiency virus type 1 and retain virus with maturation in vitro. J
M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning,
and F. Mackay. 2000. BAFF mediates survival of peripheral immature B
lymphocytes. J Exp Med 192:1453.
A., S. Wolfl, M. Schmidt, C. Brendel, B. Denecke, D. Cai, L. Odyvanova, T.
Lahaye, M. C. Muller, T. Berg, H. Gschaidmeier, B. Wittig, R. Hehlmann, A.
Hochhaus, and A. Neubauer. 2003. Interferon-a, but not the ABL-kinase inhibitor imatinib (STI571), induces expression
of myeloblastin and a specific T-cell response in chronic myeloid leukemia. Blood
S., W. Li, C. A. Wong, G. Fisher-Adams, D. Lu, M. Guha, J. A. Macer, S. J.
Forman, and K. K. Wong, Jr. 1999. Transduction of primitive human marrow and
cord blood-derived hematopoietic progenitor cells with adeno-associated virus
vectors. Blood 93:1882.
S. H., and L. W. Arnold. 1998. B-1 cell development: evidence for an
uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.
J Exp Med 187:1325.
A. M., C. Klein, P. G. Andres, C. A. London, M. P. Lodge, R. C. Mulligan, and
A. K. Abbas. 2000. Expression of Bcl-XL restores cell survival, but not
proliferation and effector differentiation, in CD28-deficient T lymphocytes. J.
Exp. Med. 191:2031.
H. E., and C. J. Paige. 2001. Pre-B cell receptor signaling mediates selective
response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP
kinase-dependent pathway. Immunity 15:521.
P., P. Transidico, J. P. Veiga, C. Schaniel, F. Sallusto, K. Matsushima, S. E.
Sallan, A. G. Rolink, A. Mantovani, L. M. Nadler, and A. A. Cardoso. 2001.
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors
following CD40 ligation and support the migration of leukemia-specific T cells.
S. R., I. Junghahn, M. Wissler, M. Becker, J. Aumann, U. Just, G.
Martiny-Baron, I. Fichtner, and R. Henschler. 2000. Donor stromal cells from
human blood engraft in NOD/SCID mice. Blood 96:3971.
R., R. P. Stephan, Z. Zhang, and M. D. Cooper. 2001. An essential role for Daxx
in the inhibition of B lymphopoiesis by type I interferons. Immunity 14:727.
H. K., S. O. Peters, C. C. Hsieh, J. Wuu, K. Vergilis, C. I. Grimaldi, J.
Reilly, J. E. Carlson, A. E. Frimberger, F. M. Stewart, and P. J. Quesenberry.
1998. The fluctuating phenotype of the lymphohematopoietic stem cell with cell
cycle transit. J Exp Med 188:393.
Henckaerts, E., H. Geiger, J. C. Langer, P. Rebollo, G.
Van Zant, and H. W. Snoeck. 2002. Genetically determined variation in the number of
phenotypically defined hematopoietic progenitor and stem cells and in their
response to early-acting cytokines. Blood 99:3947.
S., P. D. Aplan, and T. Hoang. 2002. Gradient of E2A activity in B-cell
development. Mol Cell Biol 22:886.
D. J., J. C. Aster, Y. He, A. Weng, F. G. Karnell, V. Patriub, L. Xu, S.
Bakkour, C. Rodriguez, D. Allman, and W. S. Pear. 2002. Deltex1 redirects
lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity
K. A., T. Mi, and M. A. Goodell. 1999. Hematopoietic potential of stem cells
isolated from murine skeletal muscle. PNAS U S A 96:14482.
K. A., S. M. Majka, H. Wang, J. Pocius, C. J. Hartley, M. W. Majesky, M. L.
Entman, L. H. Michael, K. K. Hirschi, and M. A. Goodell. 2001. Regeneration of
ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin
P. S., M. A. Klein, P. Schwarz, and A. Aguzzi. 2001. Efficient lymphoreticular
prion propagation requires PrP(c) in stromal and hematopoietic cells. J
S., W. Walton, and O. Smithies. 2000. Hematopoietic stem cells with
controllable tEpoR transgenes have a competitive advantage in bone marrow
transplantation. Blood 95:3710.
T., K. L. Medina, K. Oritani, and P. W. Kincade. 2001. Characteristics of early
murine B-lymphocyte precursors and their direct sensitivity to negative
regulators. Blood 97:2708.
T., V. Kumar, and P. W. Kincade. 2002. Relationships between early B- and
NK-lineage lymphocyte precursors in bone marrow. Blood 100:3672.
H., and L. M. Reid. 2000. Clonogenic hepatoblasts, common precursors for
hepatocytic and biliary lineages, are lacking classical major
histocompatibility complex class I antigen. PNAS 97:12132.
I., M. H. Huls, Z. Liu, M. Semmelmann, R. A. Krance, M. K. Brenner, C. M.
Rooney, and H. E. Heslop. 2000. CD20 monoclonal antibody (rituximab) for
therapy of Epstein-Barr virus lymphoma after hematopoietic stem-cell
transplantation. Blood 95:1502.
Lu, L. S., J. Tung, N. Baumgarth, O. Herman, M. Gleimer,
and L. A. Herzenberg. 2002. Identification of a germ-line pro-B cell subset that
distinguishes the fetal/neonatal from the adult B cell development pathway. PNAS
S. M., K. A. Jackson, K. A. Kienstra, M. W. Majesky, M. A. Goodell, and K. K.
Hirschi. 2003. Distinct progenitor populations in skeletal muscle are bone
marrow derived and exhibit different cell fates during vascular regeneration. J
Clin Invest 111:71.
M. G., T. Miyamoto, K. Akashi, and I. L. Weissman. 2002. Prospective isolation
of human clonogenic common myeloid progenitors. PNAS 99:11872.
F., and J. F. Kearney. 2000. Positive selection from newly formed to marginal
zone B cells depends on the rate of clonal production, CD19, and btk. Immunity
S. L., K. A. Jackson, F. D. Camargo, G. Ferrari, F. Mavilio, and M. A. Goodell.
2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. PNAS
D., L. Di Rago, and S. Mifsud. 2002. Synergistic and inhibitory interactions in
the in vitro control of murine megakaryocyte colony formation. Stem Cells
H. K. A., Y. Fujiwara, T. M. Schlaeger, D. Traver, and S. H. Orkin. 2003. Expression
of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood
K. A., H. Ema, and I. R. Lemischka. 1997. In vitro maintenance of highly
purified, transplantable hematopoietic stem cells. Blood 89:4337.
S. K., M. S. Dooner, and P. J. Quesenberry. 1997. Synchronized cell-cycle
induction of engrafting long-term repopulating stem cells. Blood 90:4646.
S., D. Metcalf, L. Gibson, M. L. Bath, A. W. Harris, and J. M. Adams. 1999.
Promoter elements of vav drive transgene expression in vivo throughout the
hematopoietic compartment. Blood 94:1855.
Y., H. Iwasaki, C. S. Huettner, H. S. Radomska, D. A. Gonzalez, D. G. Tenen,
and K. Akashi. 2002. Differential regulation of the human and murine CD34 genes
in hematopoietic stem cells. PNAS 99:6246.
Y., C. S. Huettner, H. S. Radomska, V. Petkova, H. Iwasaki, K. Akashi, and D.
G. Tenen. 2002. Distal elements are critical for human CD34 expression in vivo.
D. W., W. S. Stillman, Y. Yang, S. Gross, J. H. Zheng, and R. D. Irons. 1999.
An essential role for NF-kB in human CD34+
bone marrow cell survival. Blood 93:3302.
H. S., D. A. Gonzalez, Y. Okuno, H. Iwasaki, A. Nagy, K. Akashi, D. G. Tenen,
and C. S. Huettner. 2002. Transgenic targeting with regulatory elements of the
human CD34 gene. Blood 100:4410.
G. P., C. Y. Tiarks, L. Pang, J. Wuu, C. C. Hsieh, and P. J. Quesenberry. 1997.
Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor
stem cells. Blood 90:2293.
S., M. W. Retter, R. Gee, M. J. Mamula, and S. H. Clarke. 1998. Autoreactive B
cell regulation: peripheral induction of developmental arrest by
lupus-associated autoantigens. Immunity 8:209.
C., L. Bruno, F. Melchers, and A. G. Rolink. 2002. Multiple hematopoietic cell
lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood
C. C., M. C. Hu, J. Hu, J. Medeiros, and S. J. Forman. 1999. Long-term ex vivo
maintenance and expansion of transplantable human hematopoietic stem cells. Blood
C. C., M. C. Hu, J. Hu, Y. Weng, P. J. Yazaki, J. Medeiros, and S. J. Forman.
2000. A secreted and LIF-mediated stromal cell-derived activity that promotes
ex vivo expansion of human hematopoietic stem cells. Blood 95:1957.
C. C., Y. Weng, A. Mamelak, T. LeBon, M. C. Hu, and S. J. Forman. 2001. Identification
of a candidate human neurohematopoietic stem-cell population. Blood 98:2412.
A., M. Schmidt, W. Bernhardt, A. Papadimitriou, M. Azemar, W. Wels, B. Groner,
and R. Henschler. 1998. Purging of mammary carcinoma cells during ex vivo culture
of CD34+ hematopoietic progenitor cells with recombinant
immunotoxins. Blood 91:1820.
F. M., S. Zhong, J. Wuu, C. Hsieh, S. K. Nilsson, and P. J. Quesenberry. 1998.
Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 91:3681.
D. E., E. P. Bowman, A. J. Wagers, E. C. Butcher, and I. L. Weissman. 2002.
Hematopoietic stem cells are uniquely selective in their migratory response to
chemokines. J Exp Med 195:1145.
G. G., R. Y. Wang, I. Kuehnle, D. Weidner, F. Marini, M. K. Brenner, M.
Andreeff, and M. A. Goodell. 2001. A leukemic stem cell with intrinsic drug
efflux capacity in acute myeloid leukemia. Blood 98:1166.
J. F., Y. Zhan, W. F. Anderson, and Y. Zhao. 2002. Murine hematopoietic stem
cell distribution and proliferation in ablated and nonablated bone marrow
transplantation. Blood 100:3521.